POST TREATMENT EFFECTS OF NALTREXONE
纳曲酮的治疗后效果
基本信息
- 批准号:6637778
- 负责人:
- 金额:$ 38.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-26 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:alcoholism /alcohol abuse alcoholism /alcohol abuse chemotherapy behavioral /social science research tag clinical research clinical trials combination therapy human middle age (35-64) human subject human therapy evaluation longitudinal human study motivation naltrexone psychotherapy social adjustment social psychology substance abuse related behavior young adult human (21-34)
项目摘要
APPLICANT'S ABSTRACT: The long-term research goal of the applicant
investigators is to maximize the clinical effectiveness of treatment for
alcoholism. The specific aims of this protocol are to compare 3 and 6 months
of naltrexone (NTX) as an adjunct to two psychotherapies that differ in scope
and intensity. The effect of these treatments will be assessed with patients
who differ in their psychosocial need and psychosocial resources at their
disposal, and in their level of cravings for alcohol.
In this randomized clinical trial, 50 mg of NTX daily and either Motivational
Enhancement Treatment (MET), or the more comprehensive Broad Spectrum
Treatment (BST), will be provided over 12 weeks (Phase I). Following Phase I,
half of the group receiving NTX in both psychotherapy conditions will
crossover to placebo, in double-blind fashion. Daily medication will continue
for an additional 3 months (Phase II). MET will terminate in Phase I, while
those patients with greater psychosocial need and fewer psychosocial resources
may continue in BST during Phase II. Medication and BST terminate at the end
of Phase II, and patients are then followed for 12 months (Phase III).
Outcome measures during all treatment phases include: 1) drinking outcomes
(time to first drink; % days abstinent; % heavy drinking days); 2) negative
drinking consequences; and 3) psychosocial adjustment.
Overall, it is anticipated that the optimum treatment package will be one that
targets the majority of the unique psychosocial needs of the patient while
addressing the biological aspects of alcohol dependence via effective
medication management.
申请人摘要:申请人的长期研究目标
研究者的目的是最大限度地提高治疗的临床效果,
酒精中毒 本方案的具体目的是比较3个月和6个月
纳洛酮(NTX)作为两种范围不同的心理治疗的辅助药物
和强度。 这些治疗的效果将与患者一起评估
他们的社会心理需求和社会心理资源不同,
处理方式和对酒精的渴望程度。
在这项随机临床试验中,每日50 mg NTX和
增强治疗(MET),或更全面的广谱
将在12周内提供治疗(BST)(I期)。 在第一阶段之后,
在两种心理治疗条件下接受NTX的组中,
以双盲方式交叉至安慰剂。 每日用药将继续
3个月(第二阶段)。 MET将在第一阶段结束,
那些有更大的心理社会需求和更少的心理社会资源的患者
可以在第二阶段继续进行BST。 药物治疗和BST结束
然后对患者进行为期12个月的随访(III期)。
所有治疗阶段的结果指标包括:1)饮酒结果
(time首次饮酒; %戒酒天数; %重度饮酒天数); 2)阴性
饮酒的后果; 3)心理社会适应。
总的来说,预计最佳的一揽子处理方案将是
针对患者的大多数独特的心理需求,
解决酒精依赖的生物学方面,
药物管理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dena Davidson其他文献
Dena Davidson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dena Davidson', 18)}}的其他基金
RCT of Duloxetine & Pregabalin for the treatment of Gulf War Illness in Veterans
度洛西汀的 RCT
- 批准号:
8585730 - 财政年份:2014
- 资助金额:
$ 38.9万 - 项目类别:
RCT of Duloxetine & Pregabalin for the treatment of Gulf War Illness in Veterans
度洛西汀的 RCT
- 批准号:
9794750 - 财政年份:2014
- 资助金额:
$ 38.9万 - 项目类别:
RCT of Duloxetine & Pregabalin for the treatment of Gulf War Illness in Veterans
度洛西汀的 RCT
- 批准号:
9336825 - 财政年份:2014
- 资助金额:
$ 38.9万 - 项目类别:
RCT of Duloxetine & Pregabalin for the treatment of Gulf War Illness in Veterans
度洛西汀的 RCT
- 批准号:
8970691 - 财政年份:2014
- 资助金额:
$ 38.9万 - 项目类别: